Immunocore
IMCR | NASDAQ
$32.18
+$0.18 (+0.56%)
At close: Sep 21, 2026, 4:00 PM ET
$32.18
$0 (0.00%)
Pre-market:
Sep 22, 2026, 8:50 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 297.57M | 247.98M | 197.39M | 144.23M | 27.04M | 30.11M |
Cost of Revenue | 6.21M | 5.54M | 820.63K | 5.29M | n/a | 74.81M |
Gross Profit | 291.36M | 242.44M | 196.57M | 138.94M | 27.04M | -44.7M |
Operating Income | -33.74M | -56.28M | -47.2M | -42.77M | -129.42M | -86.19M |
Interest Income | 16.48M | 25.62M | 14.23M | 3.76M | 65K | 706K |
Pretax Income | -14.21M | -42.32M | -48.19M | -33.82M | -133.34M | -87.36M |
Net Income | -26.42M | -40.81M | -43.75M | -43.46M | -133.45M | -74.09M |
Selling & General & Admin | 120.62M | 121.17M | 114.35M | n/a | 82.15M | 45.74M |
Research & Development | 204.47M | 177.44M | 129.42M | 84.31M | 74.31M | 74.81M |
Other Expenses | n/a | 152.45K | n/a | 97.4M | n/a | -79.05M |
Operating Expenses | 325.09M | 298.77M | 243.77M | 181.71M | 156.46M | 41.5M |
Interest Expense | 12.17M | 18.84M | 4.08M | 5.41M | 5.57M | 3.11M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 331.31M | 304.31M | 244.59M | 187.01M | 156.46M | 116.31M |
Income Tax Expense | 12.21M | -1.48M | -4.43M | 9.65M | 111.19K | -13.27M |
Shares Outstanding (Basic) | 50.35M | 49.99M | 48.89M | 45.71M | 42.49M | 31.78M |
Shares Outstanding (Diluted) | 50.35M | 49.99M | 48.89M | 45.71M | 43.86M | 31.78M |
EPS (Basic) | -0.53 | -1.02 | -0.89 | -0.95 | -3.13 | -2.33 |
EPS (Diluted) | -0.53 | -1.02 | -0.89 | -0.95 | -3 | -2.33 |
EBITDA | 387.18K | -38.5M | -40.87M | -38.35M | -123.58M | -82.38M |
EBIT | -2.04M | -41.86M | -44.11M | -42.77M | -129.21M | -88.83M |
Depreciation & Amortization | 2.43M | 3.36M | 3.24M | 4.41M | 5.63M | 6.45M |
Add to Watchlist
Select watchlists to add or remove IMCR